• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病肠道微生物群的荟萃分析表明,其改变与肠道炎症有关。

Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation.

作者信息

Romano Stefano, Savva George M, Bedarf Janis R, Charles Ian G, Hildebrand Falk, Narbad Arjan

机构信息

Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.

Department of Neurology, University of Bonn, Bonn, Germany.

出版信息

NPJ Parkinsons Dis. 2021 Mar 10;7(1):27. doi: 10.1038/s41531-021-00156-z.

DOI:10.1038/s41531-021-00156-z
PMID:33692356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7946946/
Abstract

The gut microbiota is emerging as an important modulator of neurodegenerative diseases, and accumulating evidence has linked gut microbes to Parkinson's disease (PD) symptomatology and pathophysiology. PD is often preceded by gastrointestinal symptoms and alterations of the enteric nervous system accompany the disease. Several studies have analyzed the gut microbiome in PD, but a consensus on the features of the PD-specific microbiota is missing. Here, we conduct a meta-analysis re-analyzing the ten currently available 16S microbiome datasets to investigate whether common alterations in the gut microbiota of PD patients exist across cohorts. We found significant alterations in the PD-associated microbiome, which are robust to study-specific technical heterogeneities, although differences in microbiome structure between PD and controls are small. Enrichment of the genera Lactobacillus, Akkermansia, and Bifidobacterium and depletion of bacteria belonging to the Lachnospiraceae family and the Faecalibacterium genus, both important short-chain fatty acids producers, emerged as the most consistent PD gut microbiome alterations. This dysbiosis might result in a pro-inflammatory status which could be linked to the recurrent gastrointestinal symptoms affecting PD patients.

摘要

肠道微生物群正逐渐成为神经退行性疾病的重要调节因子,越来越多的证据表明肠道微生物与帕金森病(PD)的症状和病理生理学有关。PD通常先出现胃肠道症状,且疾病过程中伴有肠神经系统的改变。多项研究分析了PD患者的肠道微生物组,但对于PD特异性微生物群的特征尚未达成共识。在此,我们进行了一项荟萃分析,重新分析了目前可用的10个16S微生物组数据集,以研究PD患者肠道微生物群中是否存在跨队列的常见改变。我们发现PD相关微生物组存在显著改变,尽管PD与对照组之间的微生物组结构差异较小,但这些改变对研究特定的技术异质性具有稳健性。乳酸杆菌属、阿克曼氏菌属和双歧杆菌属的富集以及属于毛螺菌科和粪杆菌属的细菌(两者均为重要的短链脂肪酸生产者)的减少,是最一致的PD肠道微生物组改变。这种生态失调可能导致促炎状态,这可能与影响PD患者的反复胃肠道症状有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc3/7946946/10a48564c76e/41531_2021_156_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc3/7946946/e8f74a76fb2a/41531_2021_156_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc3/7946946/4c08b164193d/41531_2021_156_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc3/7946946/0bde8843b85f/41531_2021_156_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc3/7946946/226eebd9b085/41531_2021_156_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc3/7946946/1bfcc167778c/41531_2021_156_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc3/7946946/10a48564c76e/41531_2021_156_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc3/7946946/e8f74a76fb2a/41531_2021_156_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc3/7946946/4c08b164193d/41531_2021_156_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc3/7946946/0bde8843b85f/41531_2021_156_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc3/7946946/226eebd9b085/41531_2021_156_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc3/7946946/1bfcc167778c/41531_2021_156_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc3/7946946/10a48564c76e/41531_2021_156_Fig6_HTML.jpg

相似文献

1
Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation.帕金森病肠道微生物群的荟萃分析表明,其改变与肠道炎症有关。
NPJ Parkinsons Dis. 2021 Mar 10;7(1):27. doi: 10.1038/s41531-021-00156-z.
2
Meta-Analysis of Gut Dysbiosis in Parkinson's Disease.帕金森病肠道菌群失调的Meta 分析。
Mov Disord. 2020 Sep;35(9):1626-1635. doi: 10.1002/mds.28119. Epub 2020 Jun 18.
3
Gut bacterial profiles in Parkinson's disease: A systematic review.帕金森病的肠道细菌特征:系统评价。
CNS Neurosci Ther. 2023 Jan;29(1):140-157. doi: 10.1111/cns.13990. Epub 2022 Oct 25.
4
Gut Microbiota and Its Repercussion in Parkinson's Disease: A Systematic Review in Occidental Patients.肠道微生物群及其在帕金森病中的影响:西方患者的系统评价
Neurol Int. 2023 Jun 13;15(2):750-763. doi: 10.3390/neurolint15020047.
5
Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson's Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder.帕金森病患者中产生短链脂肪酸的肠道微生物群减少,但快速眼动睡眠行为障碍患者中未减少。
mSystems. 2020 Dec 8;5(6):e00797-20. doi: 10.1128/mSystems.00797-20.
6
The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis.肠道微生物群与帕金森病的关联:一项荟萃分析
Front Aging Neurosci. 2021 Feb 12;13:636545. doi: 10.3389/fnagi.2021.636545. eCollection 2021.
7
Dysbiosis of the Beneficial Gut Bacteria in Patients with Parkinson's Disease from India.印度帕金森病患者肠道有益细菌的生态失调
Ann Indian Acad Neurol. 2023 Nov-Dec;26(6):908-916. doi: 10.4103/aian.aian_460_23. Epub 2023 Oct 31.
8
Parkinson's Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats.帕金森病药物改变健康大鼠的小肠运动和微生物组成。
mSystems. 2022 Feb 22;7(1):e0119121. doi: 10.1128/msystems.01191-21. Epub 2022 Jan 25.
9
Inflammatory microbes and genes as potential biomarkers of Parkinson's disease.炎症微生物和基因作为帕金森病的潜在生物标志物。
NPJ Biofilms Microbiomes. 2022 Dec 24;8(1):101. doi: 10.1038/s41522-022-00367-z.
10
Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.肠道微生物群和微生物代谢物在帕金森病中的潜在作用。
Ageing Res Rev. 2021 Aug;69:101347. doi: 10.1016/j.arr.2021.101347. Epub 2021 Apr 24.

引用本文的文献

1
Gut microbial production of imidazole propionate drives Parkinson's pathologies.肠道微生物产生的咪唑丙酸会引发帕金森病病理变化。
Nat Commun. 2025 Sep 5;16(1):8216. doi: 10.1038/s41467-025-63473-4.
2
The gut microbiome promotes detoxification responses to an environmental toxicant.肠道微生物群促进对环境毒物的解毒反应。
bioRxiv. 2025 Aug 19:2025.08.14.670327. doi: 10.1101/2025.08.14.670327.
3
Altered gut microbial networks and metabolic pathways in multiple system atrophy: a comparative 16S rRNA study.多系统萎缩中肠道微生物网络和代谢途径的改变:一项比较性16S rRNA研究

本文引用的文献

1
Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions.帕金森病相关的肠道微生物组改变可预测代谢功能与疾病相关的变化。
BMC Biol. 2020 Jun 9;18(1):62. doi: 10.1186/s12915-020-00775-7.
2
Syntrophy via Interspecies H Transfer between and Underlies Their Global Cooccurrence in the Human Gut.种间 H 转移共生使 在人类肠道中全球共存。
mBio. 2020 Feb 4;11(1):e03235-19. doi: 10.1128/mBio.03235-19.
3
Dysbiosis of gut microbiota in patients with neuromyelitis optica spectrum disorders: A cross sectional study.
Front Neurosci. 2025 Aug 13;19:1623165. doi: 10.3389/fnins.2025.1623165. eCollection 2025.
4
Microbial Metabolites and Cardiovascular Dysfunction: A New Era of Diagnostics and Therapy.微生物代谢产物与心血管功能障碍:诊断与治疗的新时代。
Cells. 2025 Aug 11;14(16):1237. doi: 10.3390/cells14161237.
5
Acupuncture modulates the microbiota-gut-brain axis: a new strategy for Parkinson's disease treatment.针灸调节微生物群-肠-脑轴:一种治疗帕金森病的新策略。
Front Aging Neurosci. 2025 Aug 7;17:1640389. doi: 10.3389/fnagi.2025.1640389. eCollection 2025.
6
Microbial diversity in drug-naïve Parkinson's disease patients.未服用过药物的帕金森病患者的微生物多样性。
PLoS One. 2025 Aug 18;20(8):e0328761. doi: 10.1371/journal.pone.0328761. eCollection 2025.
7
Management of Gastrointestinal Symptoms in Parkinson's Disease.帕金森病胃肠道症状的管理
J Cent Nerv Syst Dis. 2025 Aug 13;17:11795735251370014. doi: 10.1177/11795735251370014. eCollection 2025.
8
Strain-specific effects of Desulfovibrio on neurodegeneration and oxidative stress in a Caenorhabditis elegans PD model.脱硫弧菌对秀丽隐杆线虫帕金森病模型中神经退行性变和氧化应激的菌株特异性影响。
NPJ Parkinsons Dis. 2025 Aug 11;11(1):236. doi: 10.1038/s41531-025-01102-z.
9
The Small Intestinal Microbiota and the Gut-Brain Axis in Parkinson's Disease: A Narrative Review.帕金森病中的小肠微生物群与肠-脑轴:一篇叙述性综述
Biomedicines. 2025 Jul 19;13(7):1769. doi: 10.3390/biomedicines13071769.
10
Human gut microbiome gene co-expression network reveals a loss in taxonomic and functional diversity in Parkinson's disease.人类肠道微生物群基因共表达网络揭示帕金森病中分类学和功能多样性的丧失。
NPJ Biofilms Microbiomes. 2025 Jul 24;11(1):142. doi: 10.1038/s41522-025-00780-0.
视神经脊髓炎谱系疾病患者肠道微生物失调:一项横断面研究。
J Neuroimmunol. 2020 Feb 15;339:577126. doi: 10.1016/j.jneuroim.2019.577126. Epub 2019 Dec 9.
4
Analysis of the Gut Microflora in Patients With Parkinson's Disease.帕金森病患者肠道微生物群分析
Front Neurosci. 2019 Nov 22;13:1184. doi: 10.3389/fnins.2019.01184. eCollection 2019.
5
Regulatory impairment in untreated Parkinson's disease is not restricted to Tregs: other regulatory populations are also involved.未经治疗的帕金森病中的调节功能障碍不仅限于 Tregs:其他调节群体也参与其中。
J Neuroinflammation. 2019 Nov 11;16(1):212. doi: 10.1186/s12974-019-1606-1.
6
The human gut bacteria Christensenellaceae are widespread, heritable, and associated with health.人类肠道细菌 Christensenellaceae 分布广泛、可遗传,并与健康有关。
BMC Biol. 2019 Oct 28;17(1):83. doi: 10.1186/s12915-019-0699-4.
7
Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model.帕金森病中肠道微生物群的改变以及脂多糖在人α-突触核蛋白过表达小鼠模型中的影响
Front Neurosci. 2019 Aug 7;13:839. doi: 10.3389/fnins.2019.00839. eCollection 2019.
8
Strain-Specific Anti-inflammatory Properties of Two Strains on Chronic Colitis in Mice.两种菌株对小鼠慢性结肠炎的菌株特异性抗炎特性。
Front Cell Infect Microbiol. 2019 Jul 5;9:239. doi: 10.3389/fcimb.2019.00239. eCollection 2019.
9
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.帕金森病患者的肠道微生物群改变和炎症细胞因子反应。
J Neuroinflammation. 2019 Jun 27;16(1):129. doi: 10.1186/s12974-019-1528-y.
10
Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression.帕金森病中的肠道微生物群:时间稳定性及其与疾病进展的关系。
EBioMedicine. 2019 Jun;44:691-707. doi: 10.1016/j.ebiom.2019.05.064. Epub 2019 Jun 18.